Servier today announced that VORANIGO® (vorasidenib) has been awarded The Galien Foundation's 2025 Prix Galien USA ...

The FDA announced a nationwide recall of over 140,000 bottles of a prescription cholesterol medication due to “failed ...

The researchers argue that the integration of explainable AI into clinical decision-making pipelines could reshape cancer ...

(A) The Incucyte® Apoptosis Assay allows automated imaging and quantitative analysis of every well of a 96/384-well plate, ...

Company Releases Comprehensive Ingredient Research Guide to Address Consumer Confusion in Growing Brain Health Supplement Market ...

Discover how the Amazon’s purple powerhouse, the açaí berry, is being redefined by science for its role in combating ...

Harbour BioMed (HKEX: 02142), a global biopharmaceutical company focused on the discovery and development of novel antibody therapeutics in immunology and oncology, today announced the launch of its ...

Fake honey is a global concern. New research offers quick tests to spot cheaper materials mixed into pure honey. Scientists ...

Integrated analyses of the Phase 2 PAISLEY-SLE and PAISLEY LTE studies showed that Sotyktu maintained a consistent safety profile and durable efficacy in patients with moderate-to-severe SLE with up ...

The manuscript concerns a fundamental and controversial question in Trypanosoma brucei biology and the parasite life cycle, providing further evidence that slender bloodstream forms can indeed infect ...

In two replicate Phase 3 studies, upadacitinib (RINVOQ ® ) achieved the co-primary endpoints of 50% reduction in Total Vitiligo Area Scoring Index (T-VASI 50) from baseline and 75% reduction in Facial ...

A six-metabolite plasma panel was developed and validated for gastric cancer (GC) diagnosis using UPLC-MS and machine ...